Cancer Immunotherapy

The three currently used weapons, Surgery, Radiotherapy and Chemotherapy, are symbolically compared to iron, fire and poison. The opposite of these therapies, which attempts to compensate and replace these “brutal” treatments by a less aggressive treatment, remains the mobilization of the inner defense or repair systems of affected cells. In time, the understanding of the complex phenomena occurring as a result of the reaction of the neoplastic organism and of tumor cell behavior has led to the progress, diversification and increased efficacy of Immunotherapeutic means. This has allowed the development and use of therapies based on Cytokines, Monoclonal antibodies, Chemical immunostimulators, Interferon, Tumor necrosis factor, Anti-tumor growth factor antibodies, Antiangiogenesis factors, and many others. The techniques of creating Hybridomas able to produce Monoclonal antibodies that might recognize a single antigen also give hope for both the early diagnosis and therapy of Cancer metastases.

  • Cancer Immunology
  • Cellular Immunotherapy
  • Antibody Therapy
  • Antibody Therapy
  • Cytokine Therapy
  • Cancer Targetted Therapies
  • Gene Induced Immunotherapy
  • Gene Induced Immunotherapy

Related Conference of Cancer Immunotherapy

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Immunotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in